A group of 12 experts from the Gulf Cooperation Council (GCC) worked together to identify unmet needs and create recommendations for advanced endometrial cancer. This includes cancer that cannot be removed by surgery (stage III to IV), cancer that has spread, and cancer that has come back. The effort used a structured agreement process called a modified Delphi method. In this process, experts vote on statements until they reach a certain level of agreement.
The group defined agreement as 75% to 89% of experts agreeing, and strong agreement as 90% or more. The goal was to adapt recommendations to the specific needs of the GCC region, where diagnosis and management may differ from other parts of the world.
The abstract does not report the specific recommendations or which unmet needs were identified. It also does not provide details on safety, side effects, or how the recommendations will be put into practice. No funding or conflict of interest information was included.
This is a consensus guideline, not a clinical trial. It reflects expert opinion rather than new experimental evidence. Readers should understand that such recommendations are a starting point for regional care and may change as more research becomes available. Anyone with advanced endometrial cancer should discuss their treatment with their own doctor.
Common questions
What is a modified Delphi consensus process?
It is a way for experts to reach agreement on a topic. They answer questions or vote on statements in rounds. After each round, they see how the group responded and can change their answers. The goal is to find where most experts agree. In this case, agreement meant 75% to 89% of experts, and strong agreement meant 90% or more.
Who does this guidance apply to?
It applies to people in the Gulf Cooperation Council region with advanced endometrial cancer. This includes cancer that cannot be removed by surgery (stage III to IV), cancer that has spread to other parts of the body, and cancer that has come back after treatment. The recommendations are meant to be adapted to the region's specific needs.
Does this study report specific treatment recommendations?
No. The abstract only describes the method used to develop recommendations. It does not list the specific recommendations or the unmet needs that were identified. To learn the actual guidance, you would need to read the full publication. Your doctor can help you understand what it means for your care.
Are there any side effects or safety concerns mentioned?
No side effects or safety concerns are reported in this abstract. This is a consensus process, not a treatment trial, so it does not test a drug or procedure. Safety information would come from the treatments themselves, not from this guideline. Always talk with your doctor about the risks and benefits of any treatment.
